Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr-/- mice

Lupus

Volumn 17, Issue 12, 2008, Pages 1070-1078

  Braun, N A ^a   Wade, N S ^a   Wakeland, E K ^b   Major, Amy S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Autoimmunity; High fat diet; Lupus

Indexed keywords

CHOLESTEROL; DOUBLE STRANDED DNA ANTIBODY; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CHIMERA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE PREDISPOSITION; DISEASE SEVERITY; DYSLIPIDEMIA; HEMATOPOIETIC CELL; HYPERTENSION; IRRADIATION; KIDNEY DISEASE; LIPID DIET; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ANIMALS; ANTIBODIES, ANTIPHOSPHOLIPID; ATHEROSCLEROSIS; AUTOIMMUNITY; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; DIETARY FATS; DNA; DYSLIPIDEMIAS; LIPOPROTEINS, LDL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, LDL;

EID: 60349106135     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308093551     Document Type: Article

References (39)

1. Ward, MM, Pyun, E, Studenski, S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum 1995; 8: 1492-1499.
2. Aranow, C, Ginzle, EM. Epidemiology of cardiovascular disease in systemic lupus erythematosus. Lupus 2000; 9: 166-169.
3. Lockshin, MD, Salmon, JE, Roman, MJ. Atherosclerosis and lupus: A work in progress. Arthritis Rheum 2001; 44: 2215-2217.
4. Chiu, YH, Jayawardena, J, Weiss, A. et al. Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments. J Exp Med 1999; 189: 103-110.
5. Glass, C, Witzaum, J. Atheroscleroisis. the road ahead. Cell 2001; 104: 503-516.
6. Morel, L, Rudofsky, UH, Longmate, JA, Schiffenbauer, J, Wakeland, EK. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994; 1: 219-229.
7. Mohan, C, Morel, L, Yang, P, Wakeland, EK. Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997; 159: 454-465.
8. Mohan, C, Alas, E, Morel, L, Yang, P, Wakeland, EK. Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998; 101: 1362-1372.
9. Mohan, C, Yu, Y, Morel, L, Yang, P, Wakeland, EK. Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999; 162: 6492-6502.
10. Morel, L, Mohan, C, Yu, Y, et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 1997; 158: 6019-6028.
11. Morel, L, Yu, Y, Blenman, KR, Caldwell, RA, Wakeland, EK. Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996; 7: 335-339.
12. Sobel, ES, Mohan, C, Morel, L, Schiffenbauer, J, Wakeland, EK. Genetic dissection of SLE pathogenesis: Adoptive transfer of Sle1 mediates the loss of tolerance by bone marrow-derived B cells. J Immunol 1999; 162: 2415-2421.
13. Sobel, ES, Morel, L, Baert, R, Mohan, C, Schiffenbauer, J, Wakeland, EK. Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol 2002; 169: 4025-4032.
14. Stanic, AK, Stein, CM, Morgan, AC, et al. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc Natl Acad Sci U S A 2006; 103: 7018-7023.
15. Major, AS, Fazio, S, Linton, MF. B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002; 22: 1892-1898.
16. Delgado Alves J, Ames, PR, Donohue, S, et al. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002; 46: 2686-2694.
17. Delgado Alves J Kumar S Isenberg DA. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 2003; 42: 893-899.
18. Aprahamian T Bonegio R Rizzo J et al. Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model. J Immunol 2006; 177: 3028-3034.
19. Gautier EL Huby T Ouzilleau B. et al. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler Thromb Vasc Biol 2007; 27: 1625-1631.
20. Aprahamian T Rifkin I Bonegio R. et al. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med 2004; 199: 1121-1131.
21. Roman MJ Shanker BA Davis A. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.
22. Roman MJ; Salmon JE; Sobel R; et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Am J Cardiol 2001; 87: 663-666, A611.
23. Morrow, WJ, Ohashi, Y, Hall, J, et al. Dietary fat and immune function. I. Antibody responses, lymphocyte and accessory cell function in (NZB × NZW)F1 mice. J Immunol 1985; 135: 3857-3863.
24. Lin, BF, Jeng, SJ, Chiang, BL, Huang, CC. Dietary fat affects lipids and anti-cardiolipin antibody levels in autoimmune-prone NZB/W F1 mice. Br J Nutr 1997; 77: 657-669.
25. Lin, BF, Huang, CH, Chiang, BL, Jeng, SJ. Dietary fat influences Ia antigen expression, cytokines and prostaglandin E2 production of immune cells in autoimmune-prone NZB × NZW F1 mice. Br J Nutr 1996; 75: 711-722.
26. Yumura, W, Hattori, S, Morrow, WJ, Mayes, DC, Levy, JA, Shirai, T. Dietary fat and immune function. II. Effects on immune complex nephritis in (NZB × NZW)F1 mice. J Immunol 1985; 135: 3864-3868.
27. Tisseverasinghe, A, Lim, S, Greenwood, C, Urowitz, M, Gladman, D, Fortin, PR. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2211-2219.
28. McMahon, M, Hahn, BH. Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Curr Opin Immunol 2007; 19: 633-639.
29. McMahon, M, Grossman, J, FitzGerald, J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 2006; 54: 2541-2549.
30. Thiagarajan, P. Atherosclerosis, autoimmunity, and systemic lupus erythematosus. Circulation 2001; 104: 1876-1877.
31. Vuilleumier, N, Reber, G, James, R, et al. Presence of autoantibodies to apolipoprotein A-1 in patients with acute coronary syndrome further links autoimmunity to cardiovascular disease. J Autoimmun 2004; 23: 353-360.
32. Svenungsson, E, Jensen-Urstad, K, Heimburger, M, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001; 104: 1887-1893.
33. Zhou, X, Paulsson, G, Stemme, S, Hansson, GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice. J Clin Invest 1998; 101: 1717-1725.
34. de Geest, B, Collen, D. Antibodies against oxidized LDL for non-invasive diagnosis of atherosclerotic vascular disease. Eur Heart J 2001; 22: 1517-1518.
35. Wu, JT, Wu, LL. Autoantibodies against oxidized LDL. A potential marker for atherosclerosis. Clin Lab Med 1997; 17: 595-604.
36. Steinerova, A, Racek, J, Stozicky, F, Zima, T, Fialova, L, Lapin, A. Antibodies against oxidized LDL-theory and clinical use. Physiol Res 2001; 50: 131-141.
37. Paiker, JE, Raal, FJ, von Arb, M. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia. Ann Clin Biochem 2000; 37: 174-178
38. Kobayashi, K, Tada, K, Itabe, H, et al. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus 2007; 16: 929-938.
39. George, J, Harats, D, Gilburd, B, et al. Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice. Circulation 2000; 102: 1822-1827.